Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World August 2, 2012	Monsanto wins $1bn in patent case A US court has awarded $1 billion in damages to Monsanto following a patent dispute with DuPont over crops bred to be resistant to the popular pesticide glyphosphate.
The Motley Fool January 19, 2010 Brian Orelli	Monsanto's Legal Wins Are Just the Beginning The lawyers may affect the stock price for a while.
The Motley Fool May 27, 2008 Brian Orelli	Super Seed Swap Instead of continuing to fight each other in court, agribusiness companies Syngenta and Monsanto called a truce for their never-ending patent disputes last week.
The Motley Fool August 20, 2009 Brian Orelli	Monsanto Fights Back Monsanto and DuPont have escalated their squabble over DuPont's license of Monsanto's Roundup Ready gene.
The Motley Fool April 13, 2006 Brian Gorman	Monsanto's New Challenge The ag-biotech firm faces new competitive pressures from rivals and an ongoing wariness of GM crops in Europe.
The Motley Fool September 3, 2008 Brian Orelli	Monsanto's Public-Relations Nightmare Agriculture giant Monsanto has to defend its patents without looking like it's picking on the little guy.
The Motley Fool March 31, 2004 W.D. Crotty	Monsanto in the Balance Genetically modified crops are a boon for the company.
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool August 2, 2007 Brian Orelli	Monsanto Counts Beans Agricultural giant Monsanto is one step closer to launching its new soybean. In field-testing the new seeds have demonstrated a 7%-11% increase in yield.
The Motley Fool September 28, 2005 Brian Gorman	Monsanto's Rich Pipeline The agrochemical giant's long-term health looks assured thanks to a rich product pipeline. Investors, take note.
Chemistry World May 22, 2013 Rebecca Trager	US Supreme Court rules in favour of Monsanto The Supreme Court justices upheld a lower court's ruling that a farmer, Vernon Bowman, violated Monsanto's intellectual property rights by regrowing second-generation seeds.
Chemistry World June 4, 2009 Sarah Houlton	Agrochemical firms in patent battle BASF and DuPont are squaring up for a battle over technology that makes plants resistant to commonly used herbicides.
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
Chemistry World July 8, 2010 Andrew Turley	DNA must do its job for patent protection A European court has ruled that patents for DNA do not give protection when the sequences are no longer performing the task they were inserted to do.
BusinessWeek January 21, 2010 Jack Kaskey	Monsanto Will Let Bio-Crop Patents Expire Genetically engineered soybeans will go generic, but woe to anyone that crosses the seed giant on new products.
The Motley Fool January 15, 2010 Brian Orelli	Monsanto Rounds Up Documents for the DOJ The government investigates the agriculture giant.
The Motley Fool May 6, 2009 Brian Orelli	Monsanto Kills the Love Monsanto announces that it's suing DuPont over a claimed misuse of Monsanto's herbicide-tolerant Roundup Ready technology.
InternetNews November 30, 2010	Microsoft's i4i Appeal Headed for Supreme Court Microsoft will get a chance to make its case to the U.S. Supreme Court, appealing the earlier patent infringement decision it lost to i4i.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
The Motley Fool June 22, 2004 Brian Gorman	More Green for Monsanto The full-year earnings the agribusiness giant Monsanto may not please everyone, but the company plants roots for long-term success.
Reason April 2004 Brian Doherty	Patent Sense Patents are running out on some genetically modified crop seeds.
The Motley Fool March 23, 2006 Alyce Lomax	Monsanto: Monster Stock, or Just Plain Monster? Many things seem to be going right for Monsanto. However, what price are you willing to pay for growth? Are the profits worth the risks -- and the possible long-term ramifications -- for both investors and consumers?
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool June 25, 2008 Brian Orelli	Factory-Farming Friendliness Bugs Me Syngenta and DuPont join forces for a insect-killing tech swap.
Entrepreneur April 2007 Nichole L. Torres	Unlock Ideas To stimulate economic development and innovation, the Delaware Economic Development Office, or DEDO, has guaranteed 255 donated patents -- 250 from DuPont Co. and five from Hercules Chemical Co.
The Motley Fool July 17, 2007 Brian Orelli	A Fruitful Collaboration Monsanto and BASF team up to grow better plants. Long-term investors should take it as a sign that Monsanto and BASF are putting their capital to good use.
The Motley Fool December 19, 2011 Neha Chamaria	Wrap-up of a Great Year for DuPont DuPont wraps up a year with great operational performance and growth but subdued stock performance.
InternetNews December 31, 2010 Sean Michael Kerner	Notable Tech Law Suits of 2010 The lawyers were busy last year, with a raft of corporate lawsuits flying around the tech industry. Perhaps the most common area of dispute in the tech industry concerns allegations of patent infringement and other intellectual property transgressions, though those are hardly the only challenges.
The Motley Fool January 31, 2011 Alyce Lomax	Monsanto: Winner or Sinner? This stock won't show up in my SRI portfolio. Here's why.
The Motley Fool November 23, 2011 Tamara Rutter	Daily Roundup: Today's Top Stories In today's video, we discuss TiVo, Apple, and DuPont among others.
The Motley Fool May 20, 2011 Anupama Pattanaik	Danisco and DuPont: A Delicious Duet? What chemicals and food ingredients have in common.
The Motley Fool October 27, 2010 David Lee Smith	DuPont's Decline Was Patently Explainable While DuPont saw declining earnings, its future continues to brighten.
The Motley Fool December 6, 2011 Neha Chamaria	Debugging Monsanto's Bug Concerns Doubts about Monsanto's pest-resistant seeds' efficiency grow. Should you become cautious?
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool June 26, 2007 Rich Duprey	Foolish Forecast: Monsanto's Monstrous Growth Agricultural products company Monsanto will report third-quarter 2007 financial results on Thursday. Will investors on the sidelines be green with envy?
The Motley Fool September 14, 2011 Jacob Roche	Monsanto Is Getting a Bit Big for Its Britches The company plans to increase prices even while losing competitive advantages.
The Motley Fool April 27, 2004 Alyce Lomax	DuPont Doesn't Shock Here comes more good news from the chemical company.
The Motley Fool December 15, 2005 Rich Duprey	DuPont's Sticky Situation The chemical giant pays largest civil fine ever levied over chemical used to make Teflon. Investors may want to consider how the mounting legal bills will affect their investments.
Chemistry World January 11, 2011 Andrew Turley	DuPont signs Danisco deal for $5.8 billion The deal will hit DuPont shareholders with a temporary reduction in earnings per share, but it will also take the chemical giant - which made 2009 sales of $26 billion - into an area that experts say is likely to benefit the company in the long term.
IndustryWeek May 1, 2002 Tim Stevens	Cashing In On Knowledge Patents, trademarks and trade secrets, once locked away and closely guarded, are among chemical companies' best-selling new products...
The Motley Fool January 25, 2011 David Lee Smith	DuPont Hammers the Estimates Even amid higher costs, DuPont made short work of analysts' expectations.
The Motley Fool December 6, 2011 Neha Chamaria	Does DuPont Have It All? DuPont makes for a great company with its solid numbers, great growth moves, and good dividends.
The Motley Fool April 5, 2006 Stephen D. Simpson	This GM Actually Works Monsanto's path may be strewn with weeds, but rewards could still lurk within. This is a good company, and looks to be undervalued by a mid-teens percentage. Investors, take note.
The Motley Fool May 11, 2004 Brian Gorman	Monsanto's Fallow Wheat Field Monsanto halts development of its controversial genetically modified spring wheat.
Pharmaceutical Executive March 1, 2011	A Rule of Thumb Gets Shot Down The Federal Circuit court continues its trend in tightening the standards for establishing patent damages by leapfrogging a stalled legislative process.
The Motley Fool March 2, 2005 Brian Gorman	Monsanto's Brazil Benefit Brazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.
The Motley Fool July 30, 2004 Brian Gorman	In China, Hope for Modified Seeds China leans toward allowing genetically modified crops, a potential windfall for Monsanto and competitors.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
The Motley Fool September 12, 2008 Brian Orelli	Monsanto Makes Half a Discovery Monsanto announces that it has sequenced the DNA of one of its "top-performing elite" lines of corn.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.